GRI Bio (NASDAQ: GRI) to Participate in the Healthcare Virtual Conference Presented by Maxim Group LLC and Hosted by M-Vest

by barry-jtcir | Jun 15, 2023 | Press Releases

– Live webcast fireside chat on Thursday, June 22nd at 12:00 PM ET LA JOLLA, CA, June 15, 2023 — GRI Bio, Inc. (NASDAQ: GRI) (“GRI Bio” or the “Company”), a biotechnology company advancing an innovative pipeline of Natural Killer T...

GRI Bio (NASDAQ: GRI) Announces Corporate Rebranding and Launch of New Website

by barry-jtcir | Jun 13, 2023 | Press Releases

Company reiterates commitment to providing much-needed treatment options for inflammatory, fibrotic and autoimmune diseases LA JOLLA, CA, June 13, 2023 — GRI Bio, Inc. (NASDAQ: GRI) (“GRI Bio” or the “Company”), a biotechnology company...

GRI Bio (NASDAQ: GRI) Provides Business Outlook and Highlights Upcoming Milestones for Innovative Pipeline of NKT Cell Modulators

by barry-jtcir | May 22, 2023 | Press Releases

Rapidly advancing clinical pipeline in potential high-value inflammatory, fibrotic and autoimmune diseases Leading NKT regulation technology targeting earlier in the inflammatory cascade to modulate disease progression LA JOLLA, CA, May 22, 2023 — GRI Bio, Inc....

GRI Bio (NASDAQ: GRI) to Present at the Virtual Investor New to the Street Event

by barry-jtcir | Apr 27, 2023 | Press Releases

– Live moderated webcast with members of the GRI Bio management team on Wednesday, May 3rd at 2:00 PM ET LA JOLLA, CA, April 27, 2023 — GRI Bio, Inc. (NASDAQ: GRI) (“GRI Bio” or the “Company”), a biotechnology company advancing an...

GRI Bio (NASDAQ: GRI) Announces Appointment of Leanne Kelly as Chief Financial Officer

by barry-jtcir | Apr 25, 2023 | Press Releases

– Financial executive bringing over 20 years of experience in accounting, finance and management with a foundation established from big four accounting firm LA JOLLA, CA, April 25, 2023 — GRI Bio, Inc. (NASDAQ: GRI) (“GRI Bio” or the...